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Abstract
The Janus kinase (JAK) tyrosine kinase family and JAK/STAT signal transduction pathway may act in kidney fibrogenesis. 
JAK3 expression was investigated in in vitro and in vivo models of kidney fibrosis involving oxidative stress. There was a marked 
down-regulation of JAK3 mRNA in rat kidney tubular epithelial cells (NRK52E) and fibroblasts (NRK49F) exposed to 1.0 mM 
H
2
O
2
 for 18–20 h compared with controls, which correlated with increased apoptosis and decreased mitosis in both cell lines. 
However, JAK3 protein levels were not significantly different in control and H2O2-treated epithelial and fibroblast cultures. 
JAK3 activation (phospho-tyrosine) increased in NRK52E cells and decreased in NRK49F cells with oxidative stress. STAT3 
phosphorylation decreased in both cell lines with oxidative stress compared with controls. JAK3 protein expression and localisa-
tion were investigated in kidneys using the unilateral ureteral obstruction (UUO) model (0–7 days, rats) of kidney fibrosis that in-
volves oxidative stress. JAK3 protein expression did not differ between UUO and controls; however, JAK3 localisation increased 
temporally with UUO, with strong epithelial expression in mitotic cells compared with controls. Apoptotic tubular epithelium 
showed minimal JAK3. In summary, in vitro, decreased kidney JAK3 mRNA after oxidative stress was not seen translationally. 
Differences in the activation of the JAK3/STAT3 pathway may have different consequences for renal fibrosis. In vivo, changes in 
JAK3 protein localisation, and especially its co-localisation with mitotic cells, indicate that JAK3 protein may contribute to renal 
tubular epithelial cell proliferation after oxidative stress.
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Introduction
The Janus kinase (JAK) family of signal transduction mole-
cules consist of non-receptor tyrosine kinases, which are acti-
vated in the cytoplasm rather than at the cell membrane (1). 
There are currently four characterised JAK kinases—JAK1, 
JAK2, JAK3 and TYK2. Nuclear signalling from these ki-
nases is mediated through a group of proteins known as 
signal transducers and activators of transcription (STAT). 
Seven members of this family (STAT1-4, STAT5a, STAT5b 
and STAT6) are tyrosine phosphorylated by JAKs in the 
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cytoplasm and then proceed to translocate into the nucleus 
where they act as transcription factors (2).
The role of the JAK/STAT signalling pathway has received 
limited attention in kidney fibrosis, and results regarding its 
role are disparate. Alterations in the JAK/STAT signalling 
pathway may mediate signalling initiated by reactive oxygen 
species, as well as other pro-fibrotic factors such as cytok-
ines, growth factors and angiotensin II (3, 4). Renal fibroblast 
(NRK49F) proliferation induced by advanced glycation end-
products (AGE), often formed after oxidative stress, occurred 
through a JAK/STAT-dependent pathway (3, 5, 6), but only 
in association with JAK2 activation and not any of the other 
members of the JAK family (JAK1, JAK3 or TYK2). Koike 
et al. (4) reported that JAK/STAT activation had a protective 
role against kidney fibrosis in the unilateral ureteral obstruc-
tion (UUO) model of kidney fibrosis in mice; but, Pang et al. 
(7) found that use of a STAT3 inhibitor attenuated kidney 
tubulointerstitial fibrosis in the same rodent model. JAK/
STATs were reported to be activated during pro-inflamma-
tory IL-6-induced proliferation in renal cancer cells (8). In 
a similar theme involving inflammation, Dai et al. (9) found 
that JAK signalling was activated by peritoneal dialysate in 
in vitro and in vivo kidney fibrosis models. Finally, Wiezel et 
al. (10) reported impaired JAK/STAT signalling in chronic 
kidney disease.
Multiple signalling pathways acting in parallel may be re-
sponsible for the various outcomes in renal fibrosis. We and 
others have shown that signal transduction pathways, such 
as the mitogen-activated protein kinase (MAPK) pathway, 
play an integral role in determining renal cell proliferation, 
death and the propagation of disease states in the fibrosing 
kidney, especially after oxidative stress in cell culture and in 
the UUO model in rats (11–13). In the current investigation, 
initial pilot data from microarray analysis indicated signifi-
cantly altered (decreased) levels of JAK3, but not JAK1 or 
JAK2, in kidney fibrogenesis. The purpose of this study was 
to compare JAK3 expression and activation with pathology 
in well-established models of renal fibrosis, using in vitro and 
in vivo models. The interrelationship between JAK3 and ex-
tracellular signalling-regulated kinase (ERK) was also inves-
tigated in the in vivo model of kidney fibrosis.
Materials and methods
Microarray analysis
Total RNA was extracted from matched serum-free (SF) 
control and 1.0 mM hydrogen peroxide (H
2
O
2
)-treated (18–
20 h) cell lines from three separate experiments for cDNA 
expression profiling. RNA extraction was carried out using 
the RNeasy Mini Kit (Qiagen) with combined proteinase 
K digestion as described by the manufacturer. Total RNA 
(20 µg) from SF RNA (labelled with Cy5) or 1.0 mM H
2
O
2
 
RNA (labelled with Cy3) (reverse labelling reaction was also 
performed) was mixed with 40U RNasin (Promega), 4 µg 
oligo d(T15) and 6 µg random hexamer primers (Invitrogen, 
Carlsbad, CA) and labelled using the amino-allyl (indirect) 
method according to the manufacturer’s protocol. Hybridi-
sation was carried out in 20 µg of Cot-1 DNA (Invitrogen), 
20 µg of poly dA (Sigma) and 80 µL of DIG Easy Hybridis-
ation solution (Roche Diagnostics, Castle Hill, NSW, Austra-
lia) for 14–16 h at 37°C in humidified hybridisation chambers 
(TeleChem International Inc, Sunnyvale, CA). Microarrays 
were washed twice in a pre-heated (37°C) solution of 1× sa-
line–sodium citrate (SSC) and 0.1% sodium dodecyl sulphate 
(SDS) for 5 min, then in 1× SSC for 3 min, and finally in 0.1× 
SSC for 1 min before drying by centrifugation at 100 g for 5 min. 
Microarray slides were immediately scanned in a GMS-418 
Confocal Scanner (Genetic MicroSystems/Affymetrix Inc, 
Santa Clara, CA) and images imported into ImaGene 5.0 
(BioDiscovery Inc, Marina Del Rey, CA) for data extrac-
tion. Mean signal pixel intensities and mean background 
pixel intensities for Cy3 and Cy5 channels were imported 
into GeneSpring 6 (Silicon Genetics, Redwood City, CA) and 
normalised using the Lowess algorithm to correct for intensi-
ty-dependent bias and data filtering to remove experimental 
noise and poor data before further analysis. The microarray 
chips used in this study were from the Clive and Vera Rama-
ciotti Centre for Gene Function Analysis (University of New 
South Wales, Sydney, Australia) containing 5535 oligonucle-
otides spotted onto 1 microarray slide. Gene expression was 
calculated as the ratio to the SF RNA. Genes with RNA 
differentially regulated were further segregated into lists 
of those that were either upregulated or downregulated by 
1.0 mM H
2
O
2
 treatment. Genes were selected on the basis of 
their known involvement as active constituents, regulators or 
associated components of characterised signal transduction 
pathways, in addition to their possible involvement in renal 
fibrogenesis. Of the 5535 genes spotted onto the Ramaci-
otti MWG oligo sets, image analysis involving background 
subtraction and data normalisation indicated that 76 and 81 
genes were differentially regulated by ≥ a twofold change (P < 
0.05) between SF control and 1.0 mM H
2
O
2
-treated samples 
in renal epithelial (NRK52E) and fibroblast (NRK49F) cell 
lines, respectively. The expression profile of JAK3 indicated 
that it was downregulated by 1.0 mM H
2
O
2
 treatment in both 
NRK52E and NRK49F cells by fold differences of 4.117 and 
6.417, respectively (Table 1). JAK1 and JAK2 had negligible 
alteration. Thus, JAK3 was selected for the following investi-
gation. RT-PCR was used to confirm that JAK3 cDNA levels 
were reduced in both cell lines; however, no changes were ob-
served with JAK1 and JAK2 (data not demonstrated).
In vitro oxidative stress model
Renal fibroblast (NRK49F) and epithelial (NRK52E) cell 
lines were grown to 90–100% confluence in 25 or 75 cm2 flasks 
in Dulbecco’s Modified Eagle Medium (DMEM) containing 
10% bovine calf  serum and 1000 U/mL penicillin and 1000 
µg/mL streptomycin. Cells were treated with either DMEM 
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with (control) and without serum (SF), or SF containing 
1.0 mM H
2
O
2
 for 18–24 h. This treatment concentration was 
selected because it produces a moderate amount of apoptosis 
and decreased mitosis in vitro, two characteristics of the in-
trinsic renal cells in diseases in vivo involving oxidative stress 
(12). This model has been used in other studies to define 
expression of many pro-fibrotic molecules (11). Following 
treatment, cells were analysed for apoptosis and proliferation 
or trypsinised, collected and pellets stored at –80°C prior to 
extraction of RNA or protein. For RNA analysis, the process 
was as described previously. For Western blots, established 
methods were used (14). In brief, cells were lysed directly on 
the culture plate in cell lysis buffer (0.15 M NaCl, 0.025 M 
NaF, 0.5 M EDTA, 0.1% SDS, 1.0% Igepal CA-630 in 50 mM 
Tris-Cl pH7.5) containing phosphatase and protease inhib-
itors (10 µg/mL leupeptin, 10 µg/mL aprotinin, 100 µg/mL 
phenylmethanesulphonyl fluoride, 1 mM sodium vanadate). 
Cell debris was collected by centrifugation at 16,000 g for 
15 min at 4°C and protein concentration in the supernatant 
determined using a Bradford protein assay (Bio-Rad). Excess 
protein was aliquoted and stored at −80°C.
UUO in vivo kidney fibrosis model
All experiments were performed with ethics approval from 
the University of Queensland Animal Experimentation 
Ethics Committee (Number Path/RBH/732/03/RD). Male 
Sprague-Dawley rats (N = 6 per group) weighing 180–220 g 
were used, as previously described, for a period ranging from 
0 to 7 days, and results on increasing development of fibro-
sis over this time have been previously described by us (12). 
Briefly for UUO, the left kidney was exposed with a mid-ab-
dominal incision and a double ligature placed on the left ure-
ter approximately 1 cm from the renal hilum, before closing 
the abdominal incision with 4–0 silk and Michel clips. At 
each time point, each kidney was quickly sliced transversely 
(2–3 mm slices) to the length of the kidney. The slices clos-
est to the equatorial plane were either fixed in 10% buffered 
formalin or 4% buffered paraformaldehyde for histology and 
immunohistochemistry (IHC), or snap frozen in liquid nitro-
gen for protein or RNA extraction and analysis.
Histology
Apoptosis and mitosis were assessed using morphology 
(15) following hematoxylin and eosin (H&E) staining and 
microscopy. Data were obtained by counting 10 frames of 
cells for controls and treatment and calculating the per-
centage of  apoptotic or mitotic cells. The morphological 
characteristics for apoptosis were as follows: (i) shrunken 
eosinophilic cells with condensed, marginated nuclear 
chromatin and intact cell membrane; (ii) discrete apoptotic 
bodies comprising large, dense, pyknotic nuclear fragments 
surrounded by a narrow eosinophilic cytoplasm; and (iii) 
clusters of  small apoptotic bodies (assessed as a single apop-
totic occurrence). The morphological characteristics used to 
distinguish mitosis were as follows: (i) formation of  mitotic 
spindles occurring during metaphase and remaining visible 
in anaphase or (ii) cells in the later stages of  mitosis, telo-
phase or undergoing cytokinesis. Morphological assessment 
has been confirmed as a reliable measure of  apoptosis and 
mitosis, in a similar experimental protocol using molecular 
biomarkers for apoptosis (ApopTag) and mitosis (PCNA) in 
parallel with morphology (16).
Western immunoblots
Disruption of  tissue or cells was carried out in ice-cold 
cell lysis buffer (50 mM Tris-Cl at pH 7.5, 150 mM NaCl, 
1% Nonidet P-40, 0.1% SDS, 25 mM NaF, 0.5 M EDTA) 
containing protease and phosphatase inhibitors (100 µg/
mL PMSF, 20 µg/mL leupeptin, 20 µg/mL aprotinin, 1 mM 
sodium orthovanadate, all Sigma-Aldrich products) using a 
tissue homogenizer (14). Cell debris was removed by centrif-
ugation at 16,000 g for 15 min at 4°C. Protein concentration 
was determined in each tissue extract by a Bradford protein 
assay (Bio-Rad) and spectrophotometry at 595 nm; 40 µg of 
total protein were electrophoresed on a 10% SDS polyacryl-
amide gel using a Bio-Rad mini-protean unit, transferred to 
a polyvinylidene difluoride (PVDF) membrane and blotted 
routinely with JAK3 (Neomarkers/Lab Vision, Fremont, 
CA) (1:100), ERK (1:1000) or pERK (1:1000) (both from 
Cell Signaling Technology, Beverly, MA) primary antibod-
ies and then appropriate horse-radish peroxidase conjugated 
secondary antibodies diluted (1:2000–1:5000) in 5% pow-
dered milk in Tris-buffered saline. Phosphorylated tyrosine 
(pTyr) and phosphorylated STAT3 (Invitrogen; 1:400) were 
analysed for JAK activation. Protein bands were visualised 
using enhanced chemiluminescence. X-ray film was scanned 
using a Hewlett Packard ScanJet 3200 C at 300 dpi, and Scion 
Image (β4.0.2) software was used to quantify the density of 
Table 1. Different mRNA expression profiles occur for JAK1, JAK2 and JAK3 after oxidative stress.
 JAK1 JAK2 JAK3
52E No change No change ↓ 4.117
49F No change No change ↓ 6.417
49F, NRK49F kidney fibroblast cells; 52E, NRK52E kidney epithelial cells.
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the bands in arbitrary densitometry units. Membranes were 
routinely stained with Coomassie Blue (Sigma-Aldrich), or 
actin immunoblots were used, to verify equal protein load-
ing of  lanes.
IHC and double staining
Sub-serial sections of  paraffin-embedded kidney slices 
were cut, numbered, deparaffinised and rehydrated, before 
staining with the peroxidase–anti-peroxidase IHC method 
published by us previously (17). Non-specific binding of 
peroxidase or antibodies was blocked with 0.3% H
2
O
2
 in 4% 
skim milk powder followed by incubation in diluted nor-
mal rabbit or goat serum. Primary antibodies were JAK3 
(mouse monoclonal, Neomarkers/Lab Vision, Fremont, 
CA; 1:100) or phosphorylated ERK (pERK; rabbit poly-
clonal, New England Biolabs, Beverly, MA, USA; 1:400 
dilution) and PCNA (mouse monoclonal, DAKO, Glos-
trup, Denmark; 1:50 dilution). The appropriate secondary 
antibody was applied at a dilution of  1:200 to 1:400 in Tris 
buffer. Sections were developed using the peroxidase–an-
ti-peroxidase reaction plus the chromogen diaminobenzi-
dine tetrahydrochloride (DAB) for IHC. Negative controls 
were prepared without primary antibody or with non-spe-
cific serum. Positive tissue control sections from unrelated 
studies were included. Sections were lightly counterstained 
with haematoxylin and then dehydrated in ethanols, cleared 
in xylene and mounted in Depex.
Double staining
Using paraffin-embedded sections, double antibody IHC 
was performed with pERK (1:400) and JAK3 (1:100). 
Staining procedures were identical to previous IHC meth-
ods with the exception of  the chromogen. For pERK IHC, 
sections were developed with the NovaRED™ substrate 
kit  for peroxidase detection (red label) (Vector Laborato-
ries; catalogue number SK-4800), and JAK3 was developed 
with DAB.
Results
Histology for apoptosis and mitosis
To assess any temporal association between altered JAK3 
mRNA (Table 1) and apoptosis or mitosis, percentage 
change in these parameters was investigated in control, SF 
and 1.0 mM H
2
O
2
-treated cultures of NRK49F fibroblast 
and NRF52E tubular epithelial cells at 24 h of treatment. 
Figure 1 demonstrates percentage change in apoptosis (A) 
and mitosis (B). In Figure 1A, the low levels of apoptosis in 
both cell lines for control or SF medium were significantly in-
creased compared with oxidative stress (1.0 mM H
2
O
2
). The 
increase was 10-fold greater in fibroblasts and fivefold greater 
Figure 1.  Apoptosis and mitosis in kidney fibroblast and 
tubular epithelial cells 24 h after oxidative stress. To assess 
any temporal association between altered JAK3 mRNA 
and apoptosis or mitosis, percentage change in these pa-
rameters was investigated in parallel control, serum-free 
(SF) and 1.0 mM H
2
O
2
-treated cultures of  normal rat kid-
ney fibroblast cells (NRK49F; 49F) and normal rat kidney 
tubular epithelial cells (NRF52E; 52E). In (A), the low lev-
els of  apoptosis in both cell lines for control and SF me-
dium were significantly increased with 1.0 mM H
2
O
2
. In 
(B), levels of  mitosis seen in control and SF cultures were 
significantly decreased with 1.0 mM H
2
O
2
. *P < 0.05; **P 
< 0.01 and ***P < 0.001.
in epithelial cells compared with controls. In Figure 1B, levels 
of mitosis seen in control and SF cultures were significantly 
decreased (P < 0.05) compared with 1.0 mM H
2
O
2
. Mitosis 
was almost negated in NRK52E cells with oxidative stress. 
Temporally, these changes in apoptosis and mitosis with 
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oxidative stress were associated with the decrease in JAK3 
mRNA in both cell lines.
Western blot analysis of JAK3 protein in in vitro and in 
vivo experiments
To determine if  the changes in mRNA in JAK3 were trans-
lated to the protein, extracts from control, SF and 1.0 mM 
H
2
O
2
-treated cultures were subjected to Western blotting. 
Figure 2A demonstrates JAK3 protein expression in cell 
culture experiments, for NRK49F and NRK52E cells for 
control, SF medium and medium containing 1.0 mM H
2
O
2
 
for 18–20 h. These were the same experiments used for the 
mRNA analyses (Table 1) and for histological analysis of ap-
optosis and mitosis (Figure 1). JAK3 protein expression (125 
kDa approximately) was not significantly altered from con-
trols after H
2
O
2
-treatment in either cell line, although JAK3 
expression for NRK52E in the SF treatment tended to be 
lower than the normal medium controls, and the H
2
O
2
 treat-
ment (Figure 2A). To determine if  JAK3 protein expression 
was altered in vivo, Western immunoblotting was performed 
on protein extracts from whole kidney tissue taken from 
UUO rats at 0 (control), 6 h, 1, 2, 4 and 7 days. Significant 
levels of oxidative stress and tubulointerstitial fibrosis had 
been reported by us previously at 4 days of obstruction (12). 
Figure 2B demonstrates that there was no alteration in whole 
kidney JAK3 protein from controls in UUO kidneys from 
animals with increasing duration of UUO (6 h, 24 h, 2, 4 and 
7 days).
Phosphorylation of JAK3 and association with 
phosphorylated STAT3
The differences between mRNA and protein from in vitro 
Western blot results of  JAK3 suggested post-transcrip-
tional control on JAK3. To investigate if  JAK3 activation 
(phosphorylation) was altered, pTyr of  JAK3 and phos-
phorylated STAT3 (pSTAT3) were analysed (Figure 3). In 
Figure 3A, similar to JAK3 protein expression (Figure 2A), 
pTyr of  JAK3 in tubular epithelial NRK52E cells was sig-
nificantly increased after oxidative stress. In NRK49F cells, 
although JAK protein expression was stable ( Figure 2A), 
JAK3 activation (p-Tyr) decreased with oxidative stress 
(Figure 3B), thereby correlating with the microarray re-
sults of  decreased JAK3 mRNA for these cells. In Figure 
3C, pSTAT3 expression was investigated in an attempt to 
determine its post-transcriptional association with JAK3. 
STAT3 phosphorylation was negligible in both H
2
O
2
-
treated cell lines. The SF controls for the NRK49F cells 
also had negligible pSTAT3. The pSTAT3 results were 
counterintuitive (pSTAT3 often increased in fibrosis) but 
may be the result of  loss of  pSTAT3-stimulatory cytok-
ines after SF and oxidative stress treatments. This requires 
 further study.
Localisation of JAK3 during UUO
To determine whether localisation of JAK3 altered during 
the development of kidney fibrosis during UUO (proven 
association with oxidative stress) from that seen in control 
kidneys, IHC analysis was conducted on paraffin-embedded 
sections using the same antibody to JAK3 as was used for 
Western immunoblots. Activation of JAK3 was not investi-
gated. Figure 4A shows negligible JAK3 in the cortex of con-
trol kidneys. Figure 4B demonstrates localisation of JAK3 to 
vascular endothelium (red blood cells visible in the vascular 
lumens), but little expression otherwise, in the outer stripe of 
the medulla of controls. With increasing duration of UUO, 
there was positive JAK3 staining of tubular epithelial cells 
in the cortical regions (4C, 7 days UUO demonstrated). In 
all cases, subcellular localisation of JAK3 was cytoplasmic. 
Tubular epithelium with apoptotic cells had little to no JAK3 
expression. There were very few interstitial cells (fibroblasts) 
that stained positive for JAK3. 
Figure 2. Western immunoblots of  JAK3 protein from in 
vitro and in vivo experiments. In (A), to determine qualita-
tively if  the changes in RNA in JAK3 were translated to 
protein expression, extracts from control, serum-free (SF) 
and 1.0 mM H
2
O
2
 (H)-treated cultures were subjected to 
Western blotting for NRK49F (49F) and NRK52E (52E) 
cells. JAK3 protein expression (band size 125 kDa ap-
proximately) was not altered from controls after SF and 
H
2
O
2
-treatment in 49F cells but a small increase was de-
tected after H
2
O
2
 treatment in 52E cells. The stable or in-
creased protein expression was different from mRNA levels 
which were several fold lower than controls. In (B), to de-
termine if  JAK3 protein expression was altered in vivo, 
Western immunoblotting was performed on tissue taken 
from UUO rats at 0 (control), 6 h and 24 h, and 2, 4 and 
7 days. There was no alteration in whole kidney JAK3 
protein from controls in UUO kidneys from animals with 
increasing duration of  UUO (6 h, 24 h, 2, 4 and 7 days). 
Jurkat cells were used as positive control.
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Localisation of JAK3 with pERK in vivo during UUO
Double IHC staining confirmed that JAK3 was mainly lo-
calised to tubular cells at the later stages of UUO (4–7 days 
UUO), but not associated with apoptotic epithelium in 
UUO. It is possible that JAK3 expression was in apoptotic 
cells of the epithelium and that the shrinkage of apoptotic 
cells during the death process meant the JAK3 positivity was 
not detected. This would influence the lack of co-localisation 
of JAK3 and pERK (Figure 5), with one interpretation being 
that JAK3 did not localise to apoptotic cells that occur in 
this structure (12) and the other interpretation being that the 
apoptotic cell structure precluded detection of JAK3 in the 
cytoplasm.
Discussion
We had demonstrated previously, using an in vitro model 
of oxidative stress-induced renal fibrosis, that activated or 
phosphorylated extracellular signal-regulated protein kinase 
(pERK) played a role in apoptosis of renal fibroblasts, but 
not tubular epithelium where it promoted cell growth and 
survival (11). Using the UUO model, we then found that, 
during the fibrotic process, patchy promotion of tubular epi-
thelial proliferation and survival, and interstitial cell apopto-
sis were linked spatially and temporally with increased pERK 
expression (12). There is evidence of an interactive mecha-
nistic pathway between the MAPK signalling pathway and 
JAK/STAT signalling (18, 19), and for a role for the JAK/
STAT pathway in kidney fibrosis (3–6). In this study, where 
we investigated mRNA for JAK1, JAK2 and JAK3, only 
JAK3 mRNA had any marked change using the established 
in vitro model with cells central to development of fibrosis 
(tubular epithelium and renal fibroblasts). The multifold 
change in expression was downregulation of JAK3 mRNA. 
JAK3 is a known tyrosine kinase pathway signalling mole-
cule. Our hypothesis was that, if  JAK3 mRNA was decreased 
in association with renal fibrogenesis, then JAK3 protein 
Figure 3.  Western blots showing phosphorylation of JAK3 
and STAT3. In (A) and (B), phospho-tyrosine (pTyr) of JAK3 
in tubular epithelial NRK52E (52E) and NRK49F (49F) cells 
was opposite in expression patterns after oxidative stress, with 
an increase in 52E and a decrease in 49F. In (C), phosphory-
lated STAT3 (pStat3) expression was negligible in both H
2
O
2
-
treated cell lines and the SF controls for the NRK49F cells.
Figure 4. Localisation of JAK3 during UUO. In all cases, subcellular localisation of JAK3 was cytoplasmic; (A) shows negli-
gible JAK3 in the cortex of control kidneys; (B) demonstrates localisation of JAK3 to vessels (arrows), but little expression oth-
erwise, in the medulla of controls. With increasing duration of UUO, there was positive JAK3 staining of tubular epithelial cells 
in the cortical regions (4C, 7 days UUO demonstrated). In general, apoptotic cells did not show JAK3 localisation and tubular 
epithelium with apoptotic cells had little to no JAK3 expression (arrows). The most intense staining was observed over mitotic 
epithelium (C). There were very few interstitial cells (fibroblasts) that stained positive for JAK3.
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expression would also be decreased. In contrast, we found 
that JAK3 protein levels in the cell culture oxidative stress 
experiments, experiments identical to the mRNA analysis, 
were unaltered (NRK49F) or increased (NRK52E), indicat-
ing possible post-transcriptional regulation of JAK3. This re-
port attempts to explain the disparate results found between 
mRNA and protein analyses.
The causes and molecular mechanisms mediating kidney 
fibrosis, and the diseases such as chronic kidney disease or 
diabetic nephropathy in which fibrosis plays a central role, 
are complex. Regulation and/or dysregulation of numerous 
biological processes, including oxidative stress, remodelling 
of cellular function and morphology, and disturbance of 
metabolic pathways, are all key mechanisms. The intricate 
network of transcriptional, post-transcriptional and trans-
lational processes is known to act throughout biology to 
determine functional outcomes (20). Among these, mecha-
nisms for the regulation of protein translation are not well 
understood. In our models, mRNA downregulation of JAK3 
was not replicated at protein levels in the same experimental 
conditions that produced evidence of JAK3 mRNA down-
regulation. To investigate if  JAK3 activation was altered, 
phosphorylation of tyrosine kinase (pTyr) of JAK3 protein 
was analysed. pTyr of JAK3 was significantly decreased by 
oxidative stress treatment versus control treatment in the 
kidney fibroblast NRK49F cells, thereby correlating with the 
microarray results. However, pTyr of JAK3 in tubular epithe-
lial NRK52E cells was significantly increased after oxidative 
stress. Thus, although JAK3 protein expression was stable or 
increased after oxidative stress, phosphorylation of JAK3 did 
not explain these differences between mRNA and protein in 
fibroblast and tubular epithelial cells.
A possible explanation could be that the JAK/STAT path-
way interaction determined outcome. The STATs are tyrosine 
phosphorylated by JAKs in the cytoplasm and then proceed 
to translocate into the nucleus where they act as transcrip-
tion factors (2). Liu et al. (18) have demonstrated that STAT3 
and JAK3 may act together, with JAK activation determin-
ing STAT activation, when investigating therapeutic effects 
of some cytokine inhibitors in diabetic nephropathy. There is 
other evidence that the JAK/STAT pathways act in diabetic 
nephropathy and may provide novel targets for new therapies 
(21–23). In this study, activated STAT3 (pSTAT3) expression 
was negligible in fibroblast and epithelial cell cultures treated 
with H
2
O
2
 and so again little explanation was found for the 
discrepancies in JAK3 mRNA and protein after oxidative 
stress. In the in vitro experiments, these changes were linked 
temporally with increased apoptosis and decreased cell pro-
liferation during oxidative stress, in both cell types. At least 
in kidney epithelial cells in the cell culture model, JAK3 ac-
tivation may promote fibrosis via tubular atrophy. The links 
with increased fibroblast apoptosis would indicate a role in 
modulating fibrosis. Koike et al. (4) reported that JAK/STAT 
pathway activation ameliorated kidney fibrosis, using the in 
vivo UUO model of kidney fibrosis.
Information regarding the JAK/STAT pathway and ap-
optosis are, in general, conflicting. Induction of apoptosis 
in cancer cells has been associated with the induction of the 
JAK/STAT signalling pathway after death receptor activa-
tion (24). In contrast, activation of neuronal erythropoietin 
receptors prevented apoptosis induced by N-methyl-d-aspar-
tate or nitric oxide by triggering cross-talk between the sig-
nalling pathways of JAK2 and nuclear factor-kappaB (25). 
The true role of JAK3 in renal fibrosis needs further study, 
perhaps using specific inhibitors of JAK3.
Although Western immunoblot indicated minimal change 
in the protein levels of JAK3 protein in vitro and no change 
in vivo, a comparison was made using IHC analysis of kid-
ney fibrosis that developed using the UUO model of tubu-
lointerstitial fibrosis (12). This investigation indicated altered 
localisation, particularly in the later stages of UUO, where 
expression of JAK3 was increased in cortical tubular epithe-
lial cells (but not in overall in the whole kidney). It is this ne-
phron segment that undergoes significant atrophy, involving 
apoptosis, but also regeneration, involving tubular epithelial 
cell proliferation (26). JAK3 localisation in various parts of 
the kidney may be more important than total kidney expres-
sion. In addition, use of a phosphorylated JAK3 antibody 
for the IHC analysis may have produced different results and 
needs further study.
Figure 5.  Localisation of  JAK3 with phosphorylated 
ERK (pERK) in the cortex during UUO. Double IHC 
staining confirmed JAK3 (brown staining) was mainly 
localised to tubular epithelial cells (7 days UUO demon-
strated), but not associated with apoptotic cells (examples 
arrowed). Rather, apoptosis was localised to epithelium 
expressing pERK (red stain). JAK3 and pERK did not 
co-localise.
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We have previously shown a role for the MAPK pathway, 
in particular ERK, in renal tubulointerstitial fibrosis in 
cell culture and during UUO (11, 12). Han and colleagues 
have also demonstrated a similar outcome, although they 
found activated ERK (pERK) localised to interstitial mac-
rophages in the UUO model (13). The MAPK pathway 
of  signal transduction molecules often acts in parallel or 
in synergy with other signalling pathways. Identification 
of  alternative or complementary pathways to MAPK may 
help define their role in renal fibrogenesis; however in our 
UUO study, JAK3 protein was not found to co-localise 
with pERK. JAK3 appeared to play a role in tubular cell 
survival or regeneration during fibrogenesis, as it was seen 
in association with mitotic cells in cortical tubular epithe-
lium in UUO. There did not appear to be direct “cross-talk” 
 between pERK and JAK3 as there was no co-localisation 
of  these proteins. The present results do, however, give some 
indication of  the independent functioning of  pERK and 
JAK3 in renal fibrosis.
In conclusion, the gene profiling of  renal tubular epi-
thelial and fibroblast cells under oxidative stress indicated 
significant decreases in JAK3 gene expression that was not 
mirrored by altered protein expression in the same cells. 
 Activation of  JAK3 may be a key to some of  the cellular 
changes known to occur in kidney fibrosis. This study un-
doubtedly leaves many questions unanswered but does in-
dicate that multiple signalling pathways are important in 
oxidative injury and kidney fibrogenesis, and it may be more 
important to understand their interrelationships rather than 
focusing on the role of  a single independent pathway. The 
disparate results for JAK3 mRNA and protein expression 
mean that this study cannot make a case for or against JAK3 
having a role in renal fibrosis.
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